Photo: twitter.com/mfame_guru
–
According to him, the main difference between the Russian drug from the Chumakov Institute is that it is made not from individual coronavirus antigens, but from a whole inactivated virus. “Therefore, it gives a complete set of all antigens of this virus, and this gives a complete set of all antibodies,” the specialist said.
In his opinion, this feature of the drug will best protect the body from COVID-19. In addition, Yegorov added that the vaccine will be tentatively ready in February.
To date, two COVID-19 vaccines have been registered in the country. Sputnik V was the first to register. On October 14, President Vladimir Putin announced the registration of EpiVacCorona from the Vector Center.
–
Video of the day. MMA fighter Kharitonov in the hospital after a fight with Yandiev in the Luzhniki hall
–
